Skip to main content

Table 1 Summary of SCC Tumors

From: Hypoxia-inducible factor-1α polymorphisms and TSC1/2 mutations are complementary in head and neck cancers

Patient #

Stage

Grade

HIF-1α Score

HIF-1α P/M

TSC1/2 P/M

vHL P/M

1

2

WD

2

NC

Exon 41(TSC2), P/G5346C

NC

2

3

UD

1

NC

NC

NC

3

2

WD

3

NC

NC

NC

4

1

WD

2

NC

Exon 41(TSC2), P/G5346C

NC

5

2

MD

3

Exon 12, P/C1772T

Exon 41(TSC2), P/G5346C

NC

6

4

UD

2

NC

NC

NC

7

1

WD

1

NC

Exon 41(TSC2), P/G5346C

NC

8

2

WD

4

NC

NC

NC

9

1

WD

1

NC

Exon 41(TSC2), P/G5346C

NC

10

2

MD

3

NC

NC

NC

11

3

WD

3

Exon 12, P/C1772T

Exon 41(TSC2), P/G5346C

NC

12

2

MD

1

NC

Exon 41(TSC2), P/G5346C

NC

13

1

WD

1

NC

NC

NC

14

1

WD

 

NC

NC

NC

15

3

MD

3

Exon 12, P/G1790A

NC

NC

16

2

MD

1

NC

NC

NC

17

2

WD

2

NC

NC

NC

18

2

WD

3

NC

Exon 40 (TSC2) 528_5255 del

NC

19

1

WD

2

NC

NC

NC

20

4

MD

2

NC

NC

NC

21

3

WD

3

Exon 12, P/G1790A

NC

NC

22

2

WD

1

NC

NC

NC

23

2

WD

1

NC

NC

NC

24

3

WD

2

NC

NC

NC

25

4

MD

2

NC

NC

NC

26

2

MD

3

Exon 12, P/C1772T

NC

NC

27

2

WD

2

 

NC

NC

28

3

WD

4

Exon 12, M/C1771A

Exon 36 (TSC2) 4681 delAG 40 (TSC2) 5238_5255 del 41(TSC2) P/G5346C

NC

  1. WD-Well differentiated;MD-Moderately Well-differentiated; UD-Undifferentiated;NC-No change wild-type; P-polymorphism; M-Mutation; del-deletion